Retractable Technologies Inc (RVP)
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$0.71-0.43%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · RVP
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -79.3% |
| Our one-year growth estimate | diamond | -20.2% |
Growth built into the price is above our model estimate.
The price assumes 59.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 26 industry peers · Company calendar date is not available
RVP — dividend update
Dated 2026-06-30
Other Events. On June 30, 2026, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Why it matters: More domestic production can lower tariff costs. This helps manage expenses better.
Supportive ifDomestic production goes above 39% in Q1 2026.
Worry ifDomestic production drops or stays below 39%.
Why it matters: The workforce reduction aims to save $2.2 million annually. This could improve operating income if successful.
Supportive ifOperating loss drops from $6.2 million in Q1 2026.
Worry ifOperating loss remains the same or increases beyond $6.2 million.
Why it matters: If revenue keeps falling, it shows ongoing trouble with sales.
Worry ifQ2 total net sales down year over year worse than -10%.
Less concerning ifQ2 total net sales stabilize or grow year over year.
Why it matters: Better operating income helps cut losses. It shows improved cost control.
Supportive ifOperating income gets less negative than -$6.0 million in Q2 2026.
Worry ifOperating income remains worse than -$6.0 million in Q2 2026.
Why it matters: If revenue growth in the health care sector speeds up, it may benefit RVP. This could signal a better market environment.
Supportive ifHealth care sector revenue growth speeds up again, reaching over 9%.
Worry ifSector revenue growth slows down and stays below 9%.
Why it matters: If losses go down, it means cost-saving steps are working. Ongoing losses can cause worries.
Supportive ifOperating losses for Q3 2026 are less than $5.1 million.
Worry ifOperating losses for Q3 2026 remain at or exceed $5.1 million.
Why it matters: Lower tariff costs can boost profit margins and overall profits.
Supportive ifTariff expenses in Q3 2026 remain below $50,000.
Worry ifTariff expenses in Q3 2026 exceed $50,000.
Why it matters: A return to faster revenue growth could signal a turnaround for the company. It may improve investor confidence.
Supportive ifRevenue growth is speeding up again. It is now over 10% year over year.
Worry ifRevenue growth is slowing down or is below 10% year over year.
Why it matters: Sales trends will show if management's efforts to stabilize revenue are working. A decline would signal ongoing issues.
Watch forIn Q3 2026, total net sales stay above $7.2 million. This shows stability.
Also watch forIn Q3 2026, total net sales fall below $7.2 million. This shows a continued decline.
Why it matters: GDP growth can impact healthcare spending. Strong GDP may lead to better sales for RVP.
Supportive ifGDP growth reported above 2% in the upcoming GDP report on June 25, 2026.
Worry ifGDP growth reported below 1% in the same report.
Why it matters: Higher domestic production can lower costs and help profits over time.
Supportive ifDomestic production rises above 45% of total units made in Q3 2026.
Worry ifDomestic production stays below 40%. This shows slow progress in saving costs.
Why it matters: Revenue trends will show if the company can stabilize sales after recent drops.
Watch forQ3 2026 revenue goes up compared to last year. This shows signs of stabilization.
Also watch forQ3 2026 revenue drops more than Q3 2025. This shows ongoing problems.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$114 on $10,000 · ±1.1% | How much price usually moves either way. |
| Bad day | $451 loss on $10,000 · 4.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,142 loss on $10,000 · 41.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.